Overview Safety, Tolerability and Clinical Activity of ASM-024 in Subjects With Mild Allergic Asthma Status: Completed Trial end date: 2012-01-01 Target enrollment: Participant gender: Summary The study will assess the safety, tolerability and clinical activity of ASM-024 in subjects with mild allergic asthma. Phase: Phase 2 Details Lead Sponsor: Asmacure Ltée